Alpha-(ARyl-Or heteroarylmethyl)-beta-piperidinopropanoic acid compounds as orl1-receptor antagonists

Details for Australian Patent Application No. 2006257273 (hide)

International Classifications

Event Publications

3 January 2008 PCT application entered the National Phase

PCT publication WO2006/134485 Priority application(s): WO2006/134485

7 January 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the Name Pfizer Japan Inc., Application No. 2006257273, under INID (71) correct the applicant to read Pfizer Inc.

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.